Bassukas I D, Deubel W, Schlereth W, Metz R
Institute of Medical Radiation and Cell Research (MSZ), University of Würzburg, Germany.
In Vivo. 1995 May-Jun;9(3):219-23.
The effect of a three-week treatment regimen with 2, 4 or 6 mg aurintricarboxylic acid (ATA) per kg body weight on the cell proliferation of jejunal crypts and dorsal epidermis of the nude mouse was studied using standard autoradiographic methods after in vivo pulse labelling with 3H-thymidine. ATA was slightly toxic to the animals in a dose-dependent manner (p < 0.01), as measured by the decrease of the rate of weight gain of the treated animals. In the small intestine, ATA led to a shrinkage of crypt length by a factor of 10-15% (p < 0.05), mainly by inhibiting cell proliferation in a dose-dependent manner (p < 0.05) and only secondarily and at higher doses by additionally increasing the cell loss. On the contrary, both the 3H-thymidine labelling index and the mitotic index of the basal cell layer of the epidermis are found to be increased under treatment with ATA. Thus, the present findings indicate that ATA may differentially affect the tissue homeostasis of different renewable epithelia in vivo.
在用³H-胸腺嘧啶核苷进行体内脉冲标记后,采用标准放射自显影方法,研究了每千克体重给予2毫克、4毫克或6毫克金精三羧酸(ATA)的三周治疗方案对裸鼠空肠隐窝和背部表皮细胞增殖的影响。通过测量治疗动物体重增加速率的降低情况发现,ATA对动物有轻微的剂量依赖性毒性(p<0.01)。在小肠中,ATA导致隐窝长度缩短10%至15%(p<0.05),主要是通过剂量依赖性地抑制细胞增殖(p<0.05),仅在较高剂量时其次要地且额外地增加细胞丢失。相反,在用ATA治疗的情况下,发现表皮基细胞层的³H-胸腺嘧啶核苷标记指数和有丝分裂指数均增加。因此,目前的研究结果表明,ATA可能在体内对不同可再生上皮组织的组织稳态产生不同影响。